Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
NCT01404247 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-07-13
Summary
Brief Summary
The purpose of this study is to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct). This new technology provides a very detailed cross-section picture of the cellular layers in the retina and a 3-dimensional picture of the optic nerve head and the fovea (the center of the retina that provides the most accurate vision). These images have been used by doctors for more than 5 years to help diagnose and treat adults with eye diseases, such as macular degeneration, diabetic retinopathy, retinal detachments, and melanoma. But, it has never been studied in newborns. In newborns, it would potentially help in the diagnoses of glaucoma, optic nerve hypoplasia, foveal hypoplasia, and colobomata among many other disorders. Prior to diagnosing disorders, it is necessary to establish normal values. It is the purpose of this investigation to study the retina and optic nerves in neonates to establish normal values.
After a parent of a normal newborn provides a written consent, the baby will be taken to the Eye Clinic where the instrument is located. The baby will be swaddled in one or more blankets as needed. The infants will be held in front of the instrument by a nurse. The technician will move the lens of the instrument to about 2 to 4 inches from the baby's eye. The mild light from the instrument will then enter the eye for a few seconds to obtain the desired image. The image can be captured through an immobile eye within 5 seconds. If the baby is fussy, he or she may be given a few drops of a sugar (sucrose) solution on a pacifier for calming. Although the images can usually be secured through a normal pupil, if the pupil is found to be too small, two drops of Cyclomydril will be placed on the eye for dilation. This is the eye drop used everyday in the Eye Clinic and nursery to dilate the pupils of babies. The dilation will last for about 6 to 10 hours. After the test, the baby will return to the nursery or be discharged home as intended by the Neonatology Division.
There is minimal risk associated with this investigation. The instrument is non-invasive and does not touch the eye. The babies will be swaddled and held by a nurse to prevent any contact with the machine. The eye drop to be used if needed for dilation has been used on babies at Harbor for about 30 years. It has been found to very safe. The fact that we will study only term (not premature babies) and will apply only two drops if needed should minimize any risk from the eye drop.
An ethical issue to consider is that while the study will provide important information that will undoubtedly help babies in the future, it will probably not benefit the baby being studied. However, if the baby has an undetected retinal or optic nerve problem, the study may reveal it.
Conditions
- Retinal Diseases
- Optic Nerve Diseases
Interventions
- OTHER
-
Observational: to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct).
The OCT technician will attempt to image the eyes of neonates. The neonate may be given Cyclomydril ophthalmic solution, if needed for dilation. Cyclomydril dosing for this study is 1 drop every 5 minutes times 2.
- PROCEDURE
-
OCT imaging.
All newborns meeting eligibility requirements will undergo spectral domain optical coherence tomography imaging in order to better characterize the retina and optic nerve in newborns
Sponsors & Collaborators
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
lead OTHER
Principal Investigators
-
Sherwin J Isenberg, M.D. · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 38 Weeks
- Max Age
- 42 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
High Resolution Optical Coherence Tomography
NCT05130385 ·Status: UNKNOWN
-
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
NCT05650047 ·Status: UNKNOWN
-
Registry for Severe ROP and Treatment on Visual Outcomes
NCT01559571 ·Status: COMPLETED
-
Optical Coherence Tomography (OCT) Normative Data Collection Study
NCT02014688 ·Status: COMPLETED
-
Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)
NCT00564291 ·Status: COMPLETED
-
Evaluation of Refractive Status and Ophthalmological Problems of Prematurity
NCT01045616 ·Status: COMPLETED
-
Ocular Imaging Study Using Advanced OCT
NCT02827071 ·Status: TERMINATED
-
Digital Imaging Versus Ophthalmoscopy
NCT05282147 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography
NCT01946997 ·Status: COMPLETED
-
Analysis of the Early Development of the Visual Function in Extreme Premature Infants Under 28th Weeks of Gestation
NCT00768586 ·Status: UNKNOWN
-
Retinal Investigation Using Optos OCT Device
NCT06846151 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
NCT03530449 ·Status: TERMINATED
-
Retinal Oximtery Following Treatment for Diabetic Maculopathy
NCT01549132 ·Status: COMPLETED
-
Feasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos California
NCT06063863 ·Status: COMPLETED ·Phase: NA
-
Dual Wavelength OCT
NCT03843840 ·Status: COMPLETED
-
Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye
NCT01663688 ·Status: COMPLETED
-
Spectralis OCT Repeatability and Reproducibility Study
NCT02209077 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
NCT00556114 ·Status: COMPLETED
-
Optos Versus Indirect Ophthalmoscopy for ROP Screening Examination (Optos vs BIO Study)
NCT04292015 ·Status: COMPLETED ·Phase: NA
-
Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
NCT00408720 ·Status: COMPLETED
-
OCT in Retinal Vein Occlusions
NCT01992575 ·Status: COMPLETED
-
Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography
NCT00797524 ·Status: COMPLETED
-
Optical Coherence Tomography (OCT) Normative Data Collection Study (S-2013-2)
NCT02089711 ·Status: COMPLETED
-
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034 ·Status: RECRUITING ·Phase: NA
-
Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children
NCT05615740 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA